JCI - Citations to New protective antigen of group A streptococci

Citations to this article

New protective antigen of group A streptococci

James B. Dale, … , Harry S. Courtney, David L. Hasty

James B. Dale, … , Harry S. Courtney, David L. Hasty

Published May 1, 1999
Citation Information: J Clin Invest. 1999;103(9):1261-1268. https://doi.org/10.1172/JCI5118.

View: Text | PDF

Total citations by year

Year:	2020	2019	2018	2017	2016	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	Total
Citations:	1	1	1	2	1	2	2	8	1	2	5	5	1	4	3	3	6	6	8	2	64

Citation information

Citations to this article (64)

Title and authors	Publication	Year
Rheumatic heart disease: A review of the current status of global research activity LM Dooley, TB Ahmad, M Pandey, MF Good, M Kotiw	Autoimmunity Reviews	2020
A Conserved Streptococcal Virulence Regulator Controls the Expression of a Distinct Class of M-Like Proteins JD DGama, Z Ma, H Zhang, X Liu, H Fan, ER Morris, ND Cohen, C Cywes-Bentley, GB Pier, MK Waldor, MS Gilmore	mBio	2019
The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza AM Smith, VC Huber	Viral Immunology	2018
Towards developing a vaccine for rheumatic heart disease GD Gandhi, N Krishnamoorthy, UM Motal, M Yacoub	Global Cardiology Science and Practice	2017
Local Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes R Mortensen, D Christensen, LB Hansen, JP Christensen, P Andersen, J Dietrich, VC Huber	PloS one	2017
Identifying protective Streptococcus pyogenes vaccine antigens recognized by both B and T cells in human adults and children R Mortensen, TN Nissen, S Fredslund, I Rosenkrands, JP Christensen, P Andersen, J Dietrich	Scientific Reports	2016
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus MJ Walker, TC Barnett, JD McArthur, JN Cole, CM Gillen, A Henningham, KS Sriprakash, ML Sanderson-Smith, V Nizet	Clinical microbiology reviews	2014
Group A Streptococcus Expresses a Trio of Surface Proteins Containing Protective Epitopes SE Niedermeyer, TA Penfound, C Hohn, Y Li, R Homayouni, J Zhao, JB Dale	Clinical and vaccine immunology : CVI	2014
Group A streptococcal vaccines: Paving a path for accelerated development JB Dale, VA Fischetti, JR Carapetis, AC Steer, S Sow, R Kumar, BM Mayosi, FA Rubin, K Mulholland, JM Hombach, F Schödel, AM Henao-Restrepo	Vaccine	2013
Vaccines RW Sutter, OM Kew, SL Cochi, RB Aylward	Human vaccines	2013
Host-Pathogen Interactions in Streptococcal Diseases GS Chhatwal		2012
Host-Pathogen Interactions in Streptococcal Diseases GS Chhatwal		2012
Host-Pathogen Interactions in Streptococcal Diseases GS Chhatwal		2012
Host-Pathogen Interactions in Streptococcal Diseases GS Chhatwal		2012
Host-Pathogen Interactions in Streptococcal Diseases GS Chhatwal		2012
Host-Pathogen Interactions in Streptococcal Diseases GS Chhatwal		2012
Host-Pathogen Interactions in Streptococcal Diseases GS Chhatwal		2012
Vaccination Against Rheumatic Heart Disease: A Review of Current Research Strategies and Challenges M Pandey, MR Batzloff, MF Good	Current Infectious Disease Reports	2012
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci JB Dale, TA Penfound, EY Chiang, WJ Walton	Vaccine	2011
Characterization of a new protective antigen of Streptococcus canis J Yang, Y Liu, J Xu, B Li	Veterinary Research Communications	2010
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases VG Fowler, WM Scheld, AS Bayer	Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases	2010
Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes HS Courtney, I Ofek, T Penfound, V Nizet, MA Pence, B Kreikemeyer, A Podbielski, A Podbielbski, DL Hasty, JB Dale	PloS one	2009
Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci EA Ahmed, TA Penfound, SC Brewer, PA Tennant, EY Chiang, JB Dale	European Journal of Clinical Microbiology & Infectious Diseases	2009
Vaccines under study: non-HIV vaccines K Conner, A Wuu, V Maldonado, BL Bartlett, SK Tyring	Dermatologic Therapy	2009
Localization of the equine IgG-binding domain in the fibrinogen-binding protein (FgBP) of Streptococcus equi subsp. equi M Meehan, MJ Lewis, C Byrne, D O'Hare, JM Woof, P Owen	Microbiology	2009
Relationship between Expression of the Family of M Proteins and Lipoteichoic Acid to Hydrophobicity and Biofilm Formation in Streptococcus pyogenes HS Courtney, I Ofek, T Penfound, V Nizet, MA Pence, B Kreikemeyer, A Podbielbski, DL Hasty, JB Dale, ME Falagas	PloS one	2009
Hot Topics in Infection and Immunity in Children IV A Finn, AJ Pollard		2008
Hot Topics in Infection and Immunity in Children IV A Finn, AJ Pollard		2008
Hot Topics in Infection and Immunity in Children IV A Finn, AJ Pollard		2008
Human pathogenic streptococcal proteomics and vaccine development JN Cole, A Henningham, CM Gillen, V Ramachandran, MJ Walker	PROTEOMICS – CLINICAL APPLICATIONS	2008
Comparative analysis of emmtype pattern of Group A Streptococcus throat and skin isolates from India and their association with closely related SIC, a streptococcal virulence factor V Sagar, R Kumar, NK Ganguly, A Chakraborti	BMC Microbiology	2008
Active and Passive Immunizations with the Streptococcal Esterase Sse Protect Mice against Subcutaneous Infection with Group A Streptococci M Liu, H Zhu, J Zhang, B Lei	Infection and immunity	2007
Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome MJ Rodríguez-Ortega, N Norais, G Bensi, S Liberatori, S Capo, M Mora, M Scarselli, F Doro, G Ferrari, I Garaguso, T Maggi, A Neumann, A Covre, JL Telford, G Grandi	Nature Biotechnology	2006
Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein HS Courtney, DL Hasty, JB Dale	Molecular Microbiology	2006
Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development JD McArthur, MJ Walker	Molecular Microbiology	2006
A double-blind, randomized phase II trial of the safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults SA McNeil, SA Halperin, JM Langley, B Smith, DM Baxendale, A Warren, GP Sharratt, MA Reddish, LF Fries, PE Vink, JB Dale	International Congress Series	2006
Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers SA McNeil, SA Halperin, JM Langley, B Smith, A Warren, GP Sharratt, DM Baxendale, MA Reddish, MC Hu, SD Stroop, J Linden, LF Fries, PE Vink, JB Dale	Clinical Infectious Diseases	2005
Systemic immunization with streptococcal immunoglobulin-binding protein Sib35 induces protective immunity against group A Streptococcus challenge in mice S Okamoto, Y Tamura, Y Terao, S Hamada, S Kawabata	Vaccine	2005
Dynamics of anti-M antibody response in a mouse model following intranasal infection with group A Streptococcus M-18 P Gladstone, G Varghese, KN Brahmadathan	Journal of Medical Microbiology	2005
Lipid core peptide technology and group A streptococcal vaccine delivery C Olive, MR Batzloff, I Toth	Expert Review of Vaccines	2004
Host–pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development T Areschoug, F Carlsson, M Stålhammar-Carlemalm, G Lindahl	Vaccine	2004
Reemergence of Established Pathogens in the 21st Century IW Fong, K Drlica		2004
Molecular basis of group A streptococcal virulence AL Bisno, MO Brito, CM Collins	The Lancet Infectious Diseases	2003
Selective Response of Dermal Th-1 Cells to 20-50 kDa Streptococcal Cell-Wall Proteins in Chronic Plaque Psoriasis BS Baker, JM Ovigne, VA Fischetti, A Powles, L Fry	Scandinavian Journal of Immunology	2003
Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci HS Courtney, DL Hasty, JB Dale	Infection and immunity	2003
Streptococcus pyogenes expressing M and M-like surface proteins are phagocytosed but survive inside human neutrophils L Staali, M Morgelin, L Bjorck, H Tapper	Cellular Microbiology	2003
New Bacterial Vaccines RW Ellis, BR Brodeur		2003
Reduced IFN-gamma responses associated with HLA-DR15 presentation of streptococcal cell wall proteins to dermal Th-1 cells in psoriasis Barbara S Baker, Jean-Marc Ovigne, Vincent A Fischetti, Anne Powles, Lionel Fry	Journal of Clinical Immunology	2003
Postgenomic Analysis of Four Novel Antigens of Group A Streptococcus: Growth Phase-Dependent Gene Transcription and Human Serologic Response SD Reid, NM Green, GL Sylva, JM Voyich, ET Stenseth, FR DeLeo, T Palzkill, DE Low, HR Hill, JM Musser	Journal of bacteriology	2002
Identification and characterization of a novel heme-associated cell surface protein made by Streptococcus pyogenes B Lei, LM Smoot, HM Menning, JM Voyich, SV Kala, FR Deleo, SD Reid, JM Musser	Infection and immunity	2002
Invasive group a streptococcal infections, Israel AE Moses, S Goldberg, Z Korenman, M Ravins, E Hanski, M Shapiro	Emerging infectious diseases	2002
Immunogenicity of a 26-valent group A streptococcal vaccine MC Hu, MA Walls, SD Stroop, MA Reddish, B Beall, JB Dale	Infection and immunity	2002
Presentation of the Southern Society for Clinical Investigation 2002 Founders’ Medal to Dr. James B. Dale AH Kang	The American Journal of the Medical Sciences	2002
Molecular Analysis of Group A Streptococcus Type emm18 Isolates Temporally Associated with Acute Rheumatic Fever Outbreaks in Salt Lake City, Utah JC Smoot, EK Korgenski, JA Daly, LG Veasy, JM Musser	Journal of clinical microbiology	2002
Multilocus analysis of extracellular putative virulence proteins made by group A Streptococcus: population genetics, human serologic response, and gene transcription SD Reid, NM Green, JK Buss, B Lei, JM Musser	Proceedings of the National Academy of Sciences	2001
Opsonization of T1M1 Group A Streptococcus: Dynamics of Antibody Production and Strain Specificity BK Eriksson, A Villasenor-Sierra, M Norgren, DL Stevens	Clinical Infectious Diseases	2001
Stronger Proliferative Response to Membrane Versus Cell-Wall Streptococcal Proteins by Peripheral Blood T Cells in Chronic Plaque Psoriasis BS Baker, D Brown, VA Fischetti, JM Ovigne, W Porter, A Powles, L Fry	Scandinavian Journal of Immunology	2001
Toward a genome-scale understanding of group A Streptococcus pathogenesis MR Graham, LM Smoot, BF Lei, JM Musser	Current Opinion in Microbiology	2001
The fibrinogen-binding protein (FgBP) of Streptococcus equi subsp. equi additionally binds IgG and contributes to virulence in a mouse model M Meehan, P Owen, Y Lynagh, C Woods	Microbiology	2001
Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis B Lei, FR DeLeo, NP Hoe, MR Graham, SM Mackie, RL Cole, M Liu, HR Hill, DE Low, MJ Federle, JR Scott, JM Musser	Nature Medicine	2001
Spa Contributes to the Virulence of Type 18 Group A Streptococci VJ DiRita, DG McLellan, EY Chiang, HS Courtney, DL Hasty, SC Wei, MC Hu, MA Walls, JJ Bloom, JB Dale	Infection and immunity	2001
Systemic and Mucosal Immunizations with Fibronectin-Binding Protein FBP54 Induce Protective Immune Responses against Streptococcus pyogenes Challenge in Mice JD Clements, S Kawabata, E Kunitomo, Y Terao, I Nakagawa, K Kikuchi, K Totsuka, S Hamada	Infection and immunity	2001
Pathogenesis of group A streptococcal infections MW Cunningham	Clinical microbiology reviews	2000
Identification and Characterization of thescl Gene Encoding a Group A StreptococcusExtracellular Protein Virulence Factor with Similarity to Human Collagen EI Tuomanen, S Lukomski, K Nakashima, I Abdi, VJ Cipriano, RM Ireland, SD Reid, GG Adams, JM Musser	Infection and immunity	2000

Advertisement